Coronary Artery Calcification Clinical Trial
Official title:
Characteristics of Intimal and Neoatherosclerosis in Patients With Restenosis After DES Implantation for Calcified Lesions
NCT number | NCT05451368 |
Other study ID # | plz333333 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 17, 2022 |
Est. completion date | March 31, 2023 |
Previous studies have suggested that restenosis (RS) after stenting is mainly due to smooth muscle cell proliferation and migration, but recent evidence suggests that in-stent restenosis(ISR) is associated with a number of factors. Coronary artery calcification is an independent predictor of ischaemia-mediated revascularisation 1 year after percutaneous coronary intervention (PCI) following RS.The characteristics of new neointima in patients with in-stent restenosis of calcified lesions are important issues to explore
Status | Recruiting |
Enrollment | 120 |
Est. completion date | March 31, 2023 |
Est. primary completion date | February 28, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. The patient is older than 18 years. 2. The patient had undergone coronary angiography at our hospital for PCI and had first ISR with drug-eluting stent implantation. 3. Calcified lesion greater than 5 mm in length. 4. Stent implantation time greater than 30 days. Exclusion Criteria: 1. Bridge vessel lesions following coronary artery bypass grafting. 2. Planned modification of the DAPT regimen for medical reasons or other surgical procedures requiring modification within 3 months of the index procedure. 3. Patients undergoing heart transplantation. 4. Significant angiogenic lesions in the target vessel that may prevent stent delivery and deployment. 5. Bifurcation disease lesions involving collateral branches = 2.5 mm in diameter. 6. Lesions deemed by the investigator to be unsuitable for OCT imaging (e.g., extremely curved, very distal lesions). 7. Serum creatinine > 2.0 mg/dl at the time of treatment. 8. Greater than three types of stent implantation. 9. Subjects with malignancy or other co-morbidities (i.e., severe liver, kidney, lung, or pancreatic disease with a life expectancy of less than 18 months or which may result in protocol non-compliance). |
Country | Name | City | State |
---|---|---|---|
China | ShenyangNH | Shenyang | Liaoning |
Lead Sponsor | Collaborator |
---|---|
Shenyang Northern Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean lumen area | Quantitative Indicators,the mean area bounded by the luminal border on OCT(Optical Coherence Tomography) | through study completion, an average of 1 year | |
Primary | Minimum lumen area | Quantitative Indicators,the minimum area bounded by the luminal border on OCT | through study completion, an average of 1 year | |
Primary | Maximum lumen area | Quantitative Indicators,the maximum area bounded by the luminal border on OCT | through study completion, an average of 1 year | |
Primary | Percent area stenosis | Quantitative Indicators,the (reference lumen area minus the minimum lumen area) divided by the reference lumen area, multiplied by 100. The reference segment used should be specified (proximal, distal, largest or average) on OCT | through study completion, an average of 1 year | |
Primary | Mean stent area | Quantitative Indicators,the mean area bounded by the stent border on OCT | through study completion, an average of 1 year | |
Primary | Minimum stent area | Quantitative Indicators,the Minimum area bounded by the stent border on OCT | through study completion, an average of 1 year | |
Primary | Maximum stent area | Quantitative Indicators,the Maximum area bounded by the stent border on OCT | through study completion, an average of 1 year | |
Primary | lipid-laden intima | Qualitative indicators,a diffusely bordered, signal-poor region with overlying signal-rich bands in the intima on OCT.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Calcification | Qualitative indicators,shows a well-delineated, signal-poor region with sharp borders.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Thrombi | Qualitative indicators,masses protruding into the lumen and discontinuous from the surface of the vessel wall.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Intimal rupture | Qualitative indicators,discontinuity of the fibrous cap connecting the lumen.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Neovascularization | Qualitative indicators,the presence of signal-poor holes or tubular structures with a diameter of 50 to 300 µm that are not connected to the vessel lumen.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Thin-cap fibroatheroma (TCFA) | containing intima was defined as fibrous cap thickness =65 µm at the thinnest segment and an angle of lipid tissue =180°.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Macrophage infiltration | Qualitative indicators,a bright spot with a high signal variance from the surrounding tissue.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Stent underexpansion | Qualitative indicators,Stent expansion describes the minimum stent cross-sectional area either as an absolute measure (absolute expansion), or compared with the predefined reference area, which can be the proximal, distal, largest, or average reference area (relative expansion).the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | stent fracture | Qualitative indicators,the interruption of stent continuity.the investigators measured its incidence on OCT. | through study completion, an average of 1 year | |
Primary | Uncovered struts | the ratio of uncovered-to-total stent struts per section was calculated and expressed as percent on OCT. | through study completion, an average of 1 year | |
Primary | neoatherosclerosis | neoatherosclerosis were defined by the presence of one or more of the following: lipid laden tissue ,thin-cap fibroatheroma (TCFA),neointimal calcification,Macrophage infiltration.the investigators measured its incidence . | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Unknown status |
NCT02498457 -
The Effects and Safety of Low Calcium Dialysis on Coronary Artery Calcification in Maintenance Hemodialysis Patients
|
N/A | |
Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
Completed |
NCT03314493 -
Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients
|
Phase 3 | |
Recruiting |
NCT05346068 -
The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial
|
N/A | |
Completed |
NCT02966028 -
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
|
Phase 2 | |
Completed |
NCT01992848 -
MAP-Calcification: MicroRNAs as Potential Biomarkers for Coronary Artery Calcification
|
N/A | |
Recruiting |
NCT06181240 -
Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)
|
N/A | |
Terminated |
NCT05508893 -
Screening for Coronary Artery Disease USing Primary Evaluation With Coronary CTA in Aviation Medicine (SUSPECT)
|
N/A | |
Recruiting |
NCT06075602 -
COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
|
||
Completed |
NCT05112250 -
IVL for Stent Underexpantsion
|
||
Recruiting |
NCT06379295 -
Coronary Artery Calcification Assessed on PET Scanner (PET : Positron Emission Tomography)
|
||
Completed |
NCT02913144 -
7 Year Follow-up Study of the DanRisk Population
|
N/A | |
Completed |
NCT00860847 -
Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)
|
Phase 3 | |
Not yet recruiting |
NCT04319666 -
Intravascular Balloon Lithotripsy in Left Main Stem Percutaneous Coronary Intervention
|
N/A | |
Completed |
NCT03967366 -
Melatonin and Coronary Artery Calcification
|
||
Recruiting |
NCT05818098 -
Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)
|
N/A | |
Recruiting |
NCT05283538 -
Comparison of Cardiovascular Risk Stratification in Young People With Type 1 Diabetes by Coronary Calcium Score to ESC/ESA2019 Recommendations
|
N/A | |
Recruiting |
NCT04742478 -
ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)
|
||
Recruiting |
NCT05259046 -
The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health
|
N/A | |
Recruiting |
NCT01101698 -
Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
|
Phase 4 |